公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2019 | Active Transport of Membrane Components by Self-Organization of the Min Proteins | Shih Y.-L.; Huang L.-T.; Tu Y.-M.; Lee B.-F.; Bau Y.-C.; Hong C.Y.; Lee H.-L.; Shih Y.-P.; Hsu M.-F.; Lu Z.-X.; Chen J.-S.; Chao L. | Biophysical Journal | 9 | 8 | |
2015 | Endothelial cell sensitization by death receptor fractions of an anti-dengue nonstructural protein 1 antibody induced plasma leakage, coagulopathy, and mortality in mice | Sun D.-S.; Chang Y.-C.; Lien T.-S.; King C.-C.; Shih Y.-L.; Huang H.-S.; Wang T.-Y.; Li C.-R.; Lee C.-C.; PING-NING HSU ; Chang H.-H. | Journal of Immunology | 29 | 28 | |
2008 | Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan | Liu J.-Y.; Lin H.-H.; Liu Y.-C.; Lee S.S.-J.; Chen Y.-L.; CHIEN-CHING HUNG ; Ko W.-C.; Huang C.-K.; Lai C.-H.; Chen Y.-S.; Shih Y.-L.; Chung H.-C.; Liang S.-H.; Lin J.-N. | Clinical Infectious Diseases | 52 | 48 | |
2012 | Low-intensity task-oriented exercise for ambulation-challenged residents in long-term care facilities: A randomized, controlled trial | Tsaih P.-L.; Shih Y.-L.; MING-HSIA HU | American Journal of Physical Medicine and Rehabilitation | 14 | 10 | |
2015 | Prospective double-blind randomized study on the efficacy and safety of an n-3 fatty acid enriched intravenous fat emulsion in postsurgical gastric and colorectal cancer patients | Ma C.-J.; JIN-MING WU ; Tsai H.-L.; Huang C.-W.; Lu C.-Y.; Sun L.-C.; Shih Y.-L.; Chen C.-W.; Chuang J.-F.; MING-HSUN WU ; Wang M.-Y.; MING-TSAN LIN ; Wang J.-Y. | Nutrition Journal | 44 | 39 | |
2021 | Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan | CHEN-HUA LIU ; Chen P.-Y.; Chen J.-J.; Lo C.-C.; Su W.-W.; Tseng K.-C.; CHUN-JEN LIU ; Huang C.-S.; Huang K.-J.; Yang S.-S.; Peng C.-Y.; Tsai M.-C.; Kao W.-Y.; Chang C.-Y.; Shih Y.-L.; YU-JEN FANG ; Chen C.-Y.; Lee P.-L.; Huang J.-J.; Su P.-Y.; Tseng C.-W.; CHIEN-CHING HUNG ; Chang C.-H.; Huang Y.-J.; Lai H.-C.; Chang C.-C.; Lee F.-J.; Hsieh T. Y.; JIA-HORNG KAO | Hepatology International | 14 | 14 | |
2021 | Sofosbuvir/velpatasvir plus ribavirin for child-pugh b and child-pugh c hepatitis c virus-related cirrhosis | CHEN-HUA LIU ; Chen C.-Y.; Su W.-W.; CHUN-JEN LIU ; Lo C.-C.; Huang K.-J.; Chen J.-J.; Tseng K.-C.; Chang C.-Y.; Peng C.-Y.; Shih Y.-L.; Huang C.-S.; Kao W.-Y.; Yang S.-S.; Tsai M.-C.; Wu J.-H.; Chen P.-Y.; Su P.-Y.; Hwang J.-J.; YU-JEN FANG ; Lee P.-L.; Tseng C.-W.; Lee F.-J.; Lai H.-C.; Hsieh T.-Y.; Chang C.-C.; Chang C.-H.; Huang Y.-J.; JIA-HORNG KAO | Clinical and Molecular Hepatology | 8 | 8 | |
2020 | Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment | CHEN-HUA LIU ; Chen C.-Y.; Su W.-W.; Tseng K.-C.; Lo C.-C.; CHUN-JEN LIU ; Chen J.-J.; Peng C.-Y.; Shih Y.-L.; Yang S.-S.; Huang C.-S.; Huang K.-J.; Chang C.-Y.; Tsai M.-C.; Kao W.-Y.; YU-JEN FANG ; Chen P.-Y.; Su P.-Y.; Tseng C.-W.; Huang J.-J.; Lee P.-L.; Lai H.-C.; Hsieh T.-Y.; Chang C.-H.; Huang Y.-J.; Lee F.-J.; Chang C.-C.; JIA-HORNG KAO | Gut | 26 | 27 |